How The Legend Biotech (LEGN) Story Is Shifting As Analyst Expectations Reset [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
Legend Biotech's updated analyst narrative now reflects a modest reset in expectations, with fair value revised from US$58.70 to US$57.22. This change aligns with recent Street research that pairs ongoing optimism around the Carvykti franchise with rising caution on valuation, competition, and share price swings. As you read on, you will see what is driving this shift and how to track the story as new data and opinions come through. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Legend Biotech. What Wall Street Has Been Saying ?? Bullish Takeaways RBC Capital keeps an Outperform rating and highlights what it sees as a disconnect between Legend Biotech's share price and business fundamentals, pointing to management execution on the Carvykti opportunity and consistent double digit revenue growth. Deutsche Bank argues that market share concerns are overblown, citing the large multiple myeloma patient pool an
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech (LEGN) Q2 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) Q1 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (LEGN) was downgraded by Truist Financial Corporation from "strong-buy" to "hold".MarketBeat
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
LEGN
Sec Filings
- 3/27/26 - Form 4
- 3/26/26 - Form 144
- 3/26/26 - Form 144
- LEGN's page on the SEC website